Airbus planning to accelerate production of narrow-body airliner, A220


Airbus SE, the leading multinational aerospace corporation, has announced its plans of increasing the production of its narrow-body aircraft called the A220. The company intends to produce 14 A220s every month for the next five years.

Guillaume Faury, Chief Executive at Airbus reportedly stated that the industry for commercial aircraft is likely to recover to pre-COVID19 pandemic levels between 2023-2025.

Currently, the monthly production of the A220 is five which will be increased to 6 by next year, Airbus claimed. It is also worth mentioning that the wings of this narrow body airliner are manufactured at the Spirit AeroSystems plant in Belfast, Ireland.

For those unaware, Spirit AeroSystems Inc. is a U.S.-based first-tier aerostructures manufacturer. The company has employed around 3,000 workers in Northern Ireland and is known to play a key role in the aerospace industry in the United States.

Spirit AeroSystems Inc. claimed that this year it would not be able to make a profit on the A220 program until its yearly production rates have reached about 100, meaning a monthly rate of around nine airliners.

Tom Gentile, Chief Executive, Spirit AeroSystems, Inc., stated that the production rate is expected to be attained in three to five years. As one could see the market recover and restart of air traffic, it is expected to see the rates of A220 to recover to pre-pandemic levels.

Gentile added that this would help in enhancing the program’s profitability. Hence, after 3 to 5-year, it is assumed that the A220 would be profitable.

About Airbus SE

Airbus is known to design, manufactures as well as delivers market-leading helicopters, military transports, commercial aircraft, satellites, and launch vehicles. The company also specializes in providing data services, urban mobility, secure communications, navigation as well as other solutions for consumers on a global level.

Airbus aims for a safer, better-connected, and more thriving world using a progressive strategy based on new and advanced, digital as well as scientific excellence.

Source credit: